TY - JOUR
T1 - Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein Tat
AU - Haughey, N. J.
AU - Holden, C. P.
AU - Nath, A.
AU - Geiger, J. D.
PY - 1999
Y1 - 1999
N2 - HIV-1 infection commonly leads to neuronal cell death and a debilitating syndrome known as AIDS-related dementia complex. The HIV-1 protein Tat is neurotoxic, and because cell survival as affected by the intracellular calcium concentration ([Ca2+](i)), we determined mechanisms by which Tat increased [Ca2+](i) and the involvement of these mechanisms in Tat-induced neurotoxicity. Tat increased [Ca2+](i) dose-dependently in cultured human fetal neurons and astrocytes. In neurons, but not astrocytes, we observed biphasic increases of [Ca2+](i). Initial transient increases were larger in astrocytes than in neurons and in both cell types were significantly attenuated by antagonists of inositol 1,4,5-trisphosphate (IP3)-mediated intracellular calcium release [8-(diethylamino)octyl-3,4,5-trimethoxybenzoate HCl (TMB-8) and xestospongin], an inhibitor of receptor-G1 protein coupling (pertussis toxin), and a phospholipase C inhibitor (neomycin). Tat significantly increased levels of IP3 threefold. Secondary increases of neuronal [Ca2+](i) in neurons were delayed and progressive as a result of excessive calcium influx and were inhibited by the glutamate receptor antagonists ketamine, MK-801, (±)-2-amino-5-phosphonopentanoic acid, and 6,7-dinitroquinoxaline-2,3-dione. Secondary increases of [Ca2+](i) did not occur when initial increases of [Ca2+](i) were prevented with TMB-8, xestospongin, pertussis toxin, or neomycin, and these inhibitors as well as thapsigargin inhibited Tat-induced neurotoxicity. These results suggest that Tat, via pertussis toxin-sensitive phospholipase C activity, reduces calcium release from IP3-sensitive intracellular stores, which leads to glutamate receptor-mediated calcium influx, dysregulation of [Ca2+](i), and Tat- induced neurotoxicity.
AB - HIV-1 infection commonly leads to neuronal cell death and a debilitating syndrome known as AIDS-related dementia complex. The HIV-1 protein Tat is neurotoxic, and because cell survival as affected by the intracellular calcium concentration ([Ca2+](i)), we determined mechanisms by which Tat increased [Ca2+](i) and the involvement of these mechanisms in Tat-induced neurotoxicity. Tat increased [Ca2+](i) dose-dependently in cultured human fetal neurons and astrocytes. In neurons, but not astrocytes, we observed biphasic increases of [Ca2+](i). Initial transient increases were larger in astrocytes than in neurons and in both cell types were significantly attenuated by antagonists of inositol 1,4,5-trisphosphate (IP3)-mediated intracellular calcium release [8-(diethylamino)octyl-3,4,5-trimethoxybenzoate HCl (TMB-8) and xestospongin], an inhibitor of receptor-G1 protein coupling (pertussis toxin), and a phospholipase C inhibitor (neomycin). Tat significantly increased levels of IP3 threefold. Secondary increases of neuronal [Ca2+](i) in neurons were delayed and progressive as a result of excessive calcium influx and were inhibited by the glutamate receptor antagonists ketamine, MK-801, (±)-2-amino-5-phosphonopentanoic acid, and 6,7-dinitroquinoxaline-2,3-dione. Secondary increases of [Ca2+](i) did not occur when initial increases of [Ca2+](i) were prevented with TMB-8, xestospongin, pertussis toxin, or neomycin, and these inhibitors as well as thapsigargin inhibited Tat-induced neurotoxicity. These results suggest that Tat, via pertussis toxin-sensitive phospholipase C activity, reduces calcium release from IP3-sensitive intracellular stores, which leads to glutamate receptor-mediated calcium influx, dysregulation of [Ca2+](i), and Tat- induced neurotoxicity.
KW - Glutamate receptors
KW - Human immunodeficiency virus type-1
KW - Human neurons and astrocytes
KW - Inositol trisphosphate
KW - Intracellular calcium
KW - Tat
UR - http://www.scopus.com/inward/record.url?scp=0032847276&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032847276&partnerID=8YFLogxK
U2 - 10.1046/j.1471-4159.1999.0731363.x
DO - 10.1046/j.1471-4159.1999.0731363.x
M3 - Article
C2 - 10501179
AN - SCOPUS:0032847276
VL - 73
SP - 1363
EP - 1374
JO - Journal of Neurochemistry
JF - Journal of Neurochemistry
SN - 0022-3042
IS - 4
ER -